Related Experiment Videos
Altered membrane-associated functions in chronic lymphocytic leukemia cells
International Journal of Cancer
|May 15, 1978
Summary
Chronic lymphocytic leukemia (CLL) cells exhibit impaired responses to B-cell mitogens, indicating altered cell signaling. This study reveals defects in ligand-receptor interactions crucial for B-cell activation in CLL patients.
Area of Science:
- Immunology
- Hematology
- Cell Biology
Background:
- Chronic lymphocytic leukemia (CLL) is a B-cell malignancy characterized by the accumulation of neoplastic lymphocytes.
- Understanding the functional defects in CLL cells is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the cellular response of peripheral blood lymphocytes from CLL patients to various B-cell mitogens.
- To assess membrane-associated events and ligand-receptor interactions in CLL cells.
Main Methods:
- Peripheral blood lymphocytes from CLL patients were stimulated with B-cell mitogens (anti-beta2 microglobulin, Sepharose-bound protein A, Sepharose-bound anti-human immunoglobulin, calcium ionophore A23187).
- Uptake of 86Rubidium was measured to assess cellular response.
- Surface marker capping and concentration (beta2 microglobulin) were analyzed using cytofluorometry.
Main Results:
- CLL cells showed significantly reduced responses to anti-beta2 microglobulin, Sepharose-bound protein A, and Sepharose-bound anti-human immunoglobulin.
- A subset of CLL cells responded to the calcium ionophore A23187.
- Impaired capping of surface markers, including beta2 microglobulin, was observed in CLL cells, despite normal surface concentrations.
Conclusions:
- CLL cells exhibit defective signaling pathways in response to B-cell activation stimuli.
- Ligand-receptor interactions and subsequent membrane-associated events are altered or blocked in CLL cells.
- These findings highlight intrinsic cellular defects contributing to the pathophysiology of chronic lymphocytic leukemia.